Information between 26th May 2025 - 5th July 2025
Note: This sample does not contain the most recent 2 weeks of information. Up to date samples can only be viewed by Subscribers.
Click here to view Subscription options.
| Division Votes |
|---|
|
1 Jul 2025 - Renters’ Rights Bill - View Vote Context Earl of Dundee voted Aye - in line with the party majority and against the House One of 148 Conservative Aye votes vs 0 Conservative No votes Tally: Ayes - 169 Noes - 176 |
|
1 Jul 2025 - Renters’ Rights Bill - View Vote Context Earl of Dundee voted Aye - in line with the party majority and in line with the House One of 156 Conservative Aye votes vs 0 Conservative No votes Tally: Ayes - 230 Noes - 137 |
|
3 Jul 2025 - Terrorism Act 2000 (Proscribed Organisations) (Amendment) Order 2025 - View Vote Context Earl of Dundee voted No - in line with the party majority and in line with the House One of 50 Conservative No votes vs 0 Conservative Aye votes Tally: Ayes - 16 Noes - 144 |
|
2 Jul 2025 - House of Lords (Hereditary Peers) Bill - View Vote Context Earl of Dundee voted Aye - in line with the party majority and in line with the House One of 249 Conservative Aye votes vs 0 Conservative No votes Tally: Ayes - 280 Noes - 243 |
|
2 Jul 2025 - House of Lords (Hereditary Peers) Bill - View Vote Context Earl of Dundee voted Aye - against a party majority and against the House One of 2 Conservative Aye votes vs 81 Conservative No votes Tally: Ayes - 55 Noes - 234 |
|
2 Jul 2025 - House of Lords (Hereditary Peers) Bill - View Vote Context Earl of Dundee voted Aye - against a party majority and against the House One of 23 Conservative Aye votes vs 82 Conservative No votes Tally: Ayes - 84 Noes - 263 |
|
2 Jun 2025 - Data (Use and Access) Bill [HL] - View Vote Context Earl of Dundee voted Aye - in line with the party majority and in line with the House One of 96 Conservative Aye votes vs 1 Conservative No votes Tally: Ayes - 242 Noes - 116 |
|
11 Jun 2025 - Armed Forces Commissioner Bill - View Vote Context Earl of Dundee voted Aye - in line with the party majority and in line with the House One of 178 Conservative Aye votes vs 0 Conservative No votes Tally: Ayes - 265 Noes - 161 |
|
11 Jun 2025 - Holocaust Memorial Bill - View Vote Context Earl of Dundee voted Aye - against a party majority and against the House One of 33 Conservative Aye votes vs 39 Conservative No votes Tally: Ayes - 83 Noes - 129 |
| Speeches |
|---|
|
Earl of Dundee speeches from: House of Lords (Hereditary Peers) Bill
Earl of Dundee contributed 1 speech (192 words) Report stage part two Wednesday 2nd July 2025 - Lords Chamber Leader of the House |
|
Earl of Dundee speeches from: Children’s Wellbeing and Schools Bill
Earl of Dundee contributed 1 speech (170 words) Thursday 12th June 2025 - Lords Chamber Department for Education |
|
Earl of Dundee speeches from: Holocaust Memorial Bill
Earl of Dundee contributed 1 speech (120 words) Report stage part two Wednesday 11th June 2025 - Lords Chamber Ministry of Housing, Communities and Local Government |
|
Earl of Dundee speeches from: Data (Use and Access) Bill [HL]
Earl of Dundee contributed 1 speech (210 words) Consideration of Commons amendments and / or reasons Wednesday 4th June 2025 - Lords Chamber Department for Business and Trade |
|
Earl of Dundee speeches from: Data (Use and Access) Bill [HL]
Earl of Dundee contributed 1 speech (146 words) Consideration of Commons amendments and / or reasons Monday 2nd June 2025 - Lords Chamber Department for Business and Trade |
| Written Answers |
|---|
|
Drugs: Prices
Asked by: Earl of Dundee (Conservative - Excepted Hereditary) Wednesday 4th June 2025 Question to the Department of Health and Social Care: To ask His Majesty's Government what assessment they have made of the impact of multi-indication medicines, and of the application of NICE’s cost-effectiveness assessment to such medicines. Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care) The National Health Service seeks the best value in its commercial deals for patients and taxpayers. The recent NHS Commercial Framework consultation clarified the circumstances in which indication specific pricing will be considered in England. This will help companies better understand the circumstances in which indication specific pricing may be available to support patient access to new medicines. In 2024, the National Institute of Health Research commissioned the Policy Research Unit in Economic Methods of Evaluation in Health and Social Care Interventions (EEPRU) to report on the population health effects of pricing, including indication-specific pricing. A copy of the report by the EEPRU, along with its appendices, is attached. |
|
Drugs
Asked by: Earl of Dundee (Conservative - Excepted Hereditary) Wednesday 4th June 2025 Question to the Department of Health and Social Care: To ask His Majesty's Government what discussions they have had with NHS England on multi-indication medicines. Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care) The National Health Service seeks the best value in its commercial deals for patients and taxpayers. The recent NHS Commercial Framework consultation clarified the circumstances in which indication specific pricing will be considered in England. This will help companies better understand the circumstances in which indication specific pricing may be available to support patient access to new medicines. In 2024, the National Institute of Health Research commissioned the Policy Research Unit in Economic Methods of Evaluation in Health and Social Care Interventions (EEPRU) to report on the population health effects of pricing, including indication-specific pricing. A copy of the report by the EEPRU, along with its appendices, is attached. |
|
Drugs: Prices
Asked by: Earl of Dundee (Conservative - Excepted Hereditary) Wednesday 4th June 2025 Question to the Department of Health and Social Care: To ask His Majesty's Government what assessment they have made of multi-indication medicines and their relevance to the NHS, and of the approaches to and pricing of such medicines in other countries. Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care) The National Health Service seeks the best value in its commercial deals for patients and taxpayers. The recent NHS Commercial Framework consultation clarified the circumstances in which indication specific pricing will be considered in England. This will help companies better understand the circumstances in which indication specific pricing may be available to support patient access to new medicines. In 2024, the National Institute of Health Research commissioned the Policy Research Unit in Economic Methods of Evaluation in Health and Social Care Interventions (EEPRU) to report on the population health effects of pricing, including indication-specific pricing. A copy of the report by the EEPRU, along with its appendices, is attached. |
| Live Transcript |
|---|
|
Note: Cited speaker in live transcript data may not always be accurate. Check video link to confirm. |
|
2 Jul 2025, 8:51 p.m. - House of Lords "Lords Lord Anderson of Ipswich and The Earl of Dundee added their names. No Lord Anderson apologises he cannot be had today. But he reiterated his support when I spoke " The Earl of Devon (Crossbench) - View Video - View Transcript |
|
2 Jul 2025, 8:46 p.m. - House of Lords "The Earl of Dundee because here I think we are dealing with a " Viscount Hailsham (Conservative) - View Video - View Transcript |
|
2 Jun 2025, 5:08 p.m. - House of Lords "clarity to noble Lord's, such as the Earl of Dundee, that the government agrees that these issues are important and we are working on " Baroness Jones of Whitchurch, Parliamentary Under Secretary of State (Department for Science, Innovation and Technology) (Labour) - View Video - View Transcript |
|
12 Jun 2025, 2:25 p.m. - House of Lords "for a much stronger basis and echo the Earl of Dundee about the importance of local authorities in " Baroness Blake of Leeds (Labour) - View Video - View Transcript |
| Bill Documents |
|---|
|
Jun. 30 2025
HL Bill 49-R-I Marshalled list for Report House of Lords (Hereditary Peers) Bill 2024-26 Amendment Paper Found: VISCOUNT HAILSHAM THE EARL OF DUNDEE 6_ After Clause 1, insert the following new Clause— “House of |
|
Jun. 27 2025
HL Bill 49-R Running list of amendments – 27 June 2025 House of Lords (Hereditary Peers) Bill 2024-26 Amendment Paper Found: After Clause 2 THE EARL OF DUNDEE _ After Clause 2, insert the following new Clause— “Review: impact |
|
Jun. 26 2025
HL Bill 49-R Running list of amendments – 26 June 2025 House of Lords (Hereditary Peers) Bill 2024-26 Amendment Paper Found: After Clause 2 THE EARL OF DUNDEE _ After Clause 2, insert the following new Clause— “Review: impact |
|
Jun. 25 2025
HL Bill 49-R Running list of amendments – 25 June 2025 House of Lords (Hereditary Peers) Bill 2024-26 Amendment Paper Found: to the extent that it is able. 11 House of Lords (Hereditary Peers) Bill After Clause 2 THE EARL OF DUNDEE |
|
Jun. 19 2025
HL Bill 49-R Running list of amendments – 19 June 2025 House of Lords (Hereditary Peers) Bill 2024-26 Amendment Paper Found: House of Lords (Hereditary Peers) Bill 10 After Clause 2 THE EARL OF DUNDEE ★_ After Clause 2, insert |
| APPG Publications |
|---|
|
Global Sexual and Reproductive Health and Rights APPG Document: Annual Report 2015-2016 Found: Please find full text enclosed as appendix 240B Children: Maternal Care, 17th March 2016 The Earl of Dundee |